The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives
摘要:
The synthesis and biological evaluation of a series of novel isobenzofuran-based compounds are described. The compounds were evaluated for their immunosuppressive effects of T-cell proliferation and IMPDH type II inhibitor activity in vitro, as well as their structure-activity relationships were assessed. Several compounds demonstrated highly efficacious immunosuppressive properties, especially compounds 2d, 2e, 2h and 2j, which were superior to MPA, while compounds 2k, 2m, 2n, 4c and 5d exhibited an equipotent inhibitory activity compared to MPA. Generally, it was obviously demonstrated that alpha,beta-unsaturated amides proved more potent than the diamide and urea series. The present study provides a guide for further research on development of safe and effective immunosuppressive agents. (C) 2011 Elsevier Ltd. All rights reserved.
Method for the synthesis of amides and related products from esters or ester-like compounds
申请人:Gojon-Zorrilla Gabriel
公开号:US20050027120A1
公开(公告)日:2005-02-03
A versatile, eco-friendly, and efficient method for the convenient conversion of esters and ester-like compounds into amides, peptides, carbamates, ureas, oxamides, oxamates, hydrazides, oxazolidinones, pyrazolones, oxazolidinediones, barbituric acids, and other molecules containing one or more OCN moieties in the presence of a diol or polyol is disclosed.
[EN] METHOD OF MAKING PRODRUG FOR SUSTAINED AND CONTROLLED RELEASE<br/>[FR] PROCÉDÉ DE FABRICATION D'UN PROMÉDICAMENT À LIBÉRATION PROLONGÉE ET RÉGULÉE
申请人:UNIV CINCINNATI
公开号:WO2020198431A1
公开(公告)日:2020-10-01
A novel ROS-responsive prodrug is provided. The prodrug utilizes a unique modified oxalate linker conjugated to 4-aminophenol, which can enhance the reaction kinetics for intracellular ROS within tumor tissues while keeping the modified oxalate backbone stable with amide bond under very low ROS level.
Field-Induced Slow Magnetic Relaxation of a Six-Coordinate Mononuclear Manganese(II) and Cobalt(II) Oxamate Complexes
作者:Tamyris T. da Cunha、Vitor M. M. Barbosa、Willian X. C. Oliveira、Emerson F. Pedroso、Diana M. A. García、Wallace C. Nunes、Cynthia L. M. Pereira
DOI:10.1021/acs.inorgchem.0c01628
日期:2020.9.21
Two air-stable, isostructural, mononuclear six-coordinate manganese(II) and cobalt(II) oxamate complexes, [M(4-HOpa)2(H2O)2] [4-HOpa = N-4-hydroxyphenyloxamate; M= Mn2+ (1) or Co2+ (2)], exhibit field-induced slow magnetic relaxation. A bottleneck process is observed throughout the temperature range of 2–20 K for 1, while for 2, it dominates only at low temperatures (2–4 K). Additionally, the Raman
两种空气稳定的,同构的单核六配位锰(II)和草酸钴(II)配合物,[ M(4-HOpa)2(H 2 O)2 ] [4-HOpa = N -4-羟基苯基草氨酸;M= Mn 2+(1)或Co 2+(2)],表现出场诱导的慢磁弛豫。对于1,在2–20 K的整个温度范围内均观察到瓶颈过程,而对于2,仅在低温(2-4 K)时才占主导地位。此外,拉曼过程[ n = 6.9(2)]导致高温下的弛豫时间增加至2。
Utilisation de dérivés oxamates comme agents dépigmentants
申请人:L'OREAL
公开号:EP0898956B1
公开(公告)日:2001-10-04
[EN] CASPASE INHIBITORS AS THERAPEUTICS FOR NEURAL AND ORGAN INJURY AND IMAGING<br/>[FR] INHIBITEURS DE LA CASPASE UTILISÉS COMME AGENTS THÉRAPEUTIQUES CONTRE UNE LÉSION NEURALE OU D'ORGANE ET POUR L'IMAGERIE
申请人:BANYAN BIOMARKERS
公开号:WO2012021800A2
公开(公告)日:2012-02-16
Compounds, pharmaceutically acceptable salts thereof, and compositions useful as caspase inhibitors are disclosed. Certain compounds are also useful for the treatment of neural or organ injury. Other compounds are useful as neural and organ-specific imaging agents.